PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer.

Bate, J; Baker, S; Breuer, J; Chisholm, J; Gray, J; Hambleton, S; Houlton, A; Jit, M; Lowis, S; Makin, Guy W J; O'Sullivan, C; Patel, S; Phillips, R; Ransinghe, N; Ramsay, M; Skinner, R; Wheatley, K; Heath, P

Affiliation

Department of Paediatric Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK

Issue Date

2018-05-05

Metadata

Show full item record

Abstract

To determine the likely rate of patient randomisation and to facilitate sample size calculation for a full-scale phase III trial of varicella zoster immunoglobulin (VZIG) and aciclovir as postexposure prophylaxis against chickenpox in children with cancer.

Citation

PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer. 2018, Arch Dis Child

Journal

Archives of disease in childhood

URI

http://hdl.handle.net/10541/621033

DOI

10.1136/archdischild-2017-314212

PubMed ID

29730641

Type

Article

Language

ISSN

1468-2044

Collections

All Christie Publications